General
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout
Guanylate-binding protein 1 (GBP1) is farnesylated at cysteine 589 (C589) (Nantais et al., 1996; Fres JM et al., 2010; Fisch et al., 2019; Shydlovskyi et al., 2017). Farnesylation is a type of prenylation in which a 15-carbon farnesyl (FARN) isoprenoid group, donated by farnesyl diphosphate (FPP), is covalently attached to a cysteine residue on a protein. This reaction is catalyzed by the enzyme farnesyltransferase (FNT), a heterodimer composed of an alpha subunit, FNTA (shared with another prenylating enzyme, geranylgeranyltransferase or GGTase), and a unique beta subunit, FNTB (Long SB et al., 2001; deSolms et al., 2003). The FNTA:FNTB complex recognizes the CAAX box motif at the C-terminus of target proteins, where C = cysteine, A = any aliphatic amino acid, and X = any amino acid. In the case of GBP1, the CAAX motif is CTIS. In the absence of nucleotides, the farnesyl group of GBP1 is sequestered in a hydrophobic pocket, maintaining the protein in an inactive, monomeric conformation (Lorenz et al., 2020; Sistemich et al., 2020). Upon GTP binding, farnesylated GBP1 undergoes a nucleotide-dependent "farnesyl switch," which releases the farnesyl tail from the hydrophobic pocket, enabling membrane binding and polymerization into large structures (Sistemich et al., 2020; Kuhm et al., 2025). Farnesylated GBP1 localizes to the microbial membranes (reviewed by Tretina K et al., 2019). For instance, GBP1 localizes to the lipopolysaccharide (LPS)-rich outer membranes of cytosolic Gram-negative bacteria, where it oligomerizes and facilitates the assembly of a caspase-4–activating platform (Santos et al., 2020; Wandel et al., 2020; Dickinson et al., 2023). Once prenylated, CAAX-containing proteins undergo proteolytic cleavage of the terminal AAX tripeptide. This reaction is catalyzed by endopeptidases such as RAS-converting enzyme 1 (RCE1), resulting in exposure of the prenylated cysteine as the new C-terminus. The exposed cysteine can then be methylated by isoprenylcysteine carboxyl methyltransferase (ICMT) (reviewed by Wang M & Casey PJ 2016; Cansado J 2017). This sequence of post-translational modifications is considered a common mechanism by which CAAX-containing proteins, including GBP1, GBP2, and GBP5, are activated. However, there is no direct evidence for proteolytic removal of the C-terminal tripeptide or ICMT-mediated methylation of the C-terminal cysteine in GBPs; therefore, these steps are not depicted here.